Videos

In honor of Diabetes Awareness Month, the ADA put together video clips of health care professionals pledging to stop diabetes.

Alexander Mauskop, MD, director of the New York Headache Center, discusses the symptoms and causes of hemiplegic migraines.

Dr. Verbalis, Dr. Green, and Dr. Miller explain the effects of hyponatremia and Marilyn Getty describes her experience with the condition.

Nearly 80% of people worldwide who need palliative care do not have access to needed medicine and treatment.

Daniel A. Osman, MD, talks about detecting malignant tumors in patients

A video and animated overview of a laparoscopic surgical technique used in the treatment of GERD.

This video reviews the use of pacemakers, ICDs, and other implantable devices for patients with heart rhythm disorders.

UCSF cardiologist Gregory Marcus, MD, discusses, the causes, prevention, and management of atrial fibrillation.

Video explores current options for managing hypertension and atherosclerosis.

A smart chip that can measure and stop pain signals from travelling to the brain may be used soon in human trials.

Video diary depicting life with epidermolysis bullosa, a painful and potentially lethal blistering skin condition that affects thousands of children.

See how the introduction of thorazine to the market changed the face of psychiatry practice.

Dr. Nina Silverberg of the National Institute on Aging, discusses Alzheimer's Disease.

Former ADA President Gerald Bernstein discusses the history of and recent advances in the delivery of insulin.

The risk of developing ulcerative colitis and Crohn's disease is associated with iron levels in drinking water, according to a study in Norway.

A 58-year-old woman with a longstanding history of hypertension presented with numbness on the right side of the body and drooping of the right side of the face. The episode lasted about 30 minutes, after which there was a significant improvement of symptoms... Read the rest of the case report inside and take the quiz!

David R. Gandara, MD, professor of Medicine, University of California Davis Comprehensive Cancer Center, discusses the initial results of the ongoing MYSTIC trial, which is exploring the combination of durvalumab (Imfinzi) and tremelimumab versus chemotherapy in stage IV lung cancer.